Bavarian Nordic
187.6
DKK
-2.75 %
BAVA
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
50 following
-2.75%
-5.44%
-21.67%
+20.49%
+5.72%
+5.81%
-29.47%
+41.84%
+31.53%
Bavarian Nordic is a biochemistry company. Today, the company specializes in the development, manufacture, and distribution of vaccines against infectious diseases in connection with cancer treatment. In addition, vaccines against other serious diseases such as Ebola and cervical cancer are also being developed. The largest operations are located in Europe and in the U.S. Bavarian Nordic was founded in 1994 and is headquartered in Kvistgaard, Denmark.
Read moreMarket cap
14.79B DKK
Turnover
70.23M DKK
Revenue
7.06B
EBIT %
21.28 %
P/E
9.77
Dividend yield-%
-
Coverage
Financial calendar
5/3
2025
Annual report '24
9/4
2025
General meeting '24
9/5
2025
Interim report Q1'25
ShowingAll content types
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools